C
Character Biosciences
Biotech & Life Sciences · Clifton, United States · Founded 2019
Biopharmaceutical research and development company MoreLess
Clover Therapeutics is a biopharmaceutical research and development company dedicated to advancing new treatments for diseases related to aging. The company operates in the healthcare and pharmaceutical markets, focusing on innovative drug development. Clover Therapeutics collaborates with a wide range of clients, including patients, healthcare providers, payers (insurance companies), and other research organizations.
The business model of Clover Therapeutics revolves around leveraging multidisciplinary partnerships to gather and analyze clinical data. By integrating genetic information with longitudinal clinical records (data collected over a long period), the company aims to improve the understanding of age-related diseases. This approach helps in accelerating the development of targeted medicines, which are drugs designed to treat specific conditions more effectively.
Clover Therapeutics makes money primarily through partnerships with biopharmaceutical organizations. These partnerships involve collaborative research and development efforts to bring new medical discoveries to the clinic. Additionally, the company benefits from its affiliation with Clover Health, a healthcare provider, which helps in structuring and curating valuable clinical data for research purposes.
The company is committed to ensuring that the insights required for future medical discoveries are gathered in a rigorous and ethical manner. By making clinical research a seamless and accessible part of the healthcare workflow, Clover Therapeutics aims to enhance the value patients gain from clinical research.
In summary, Clover Therapeutics is at the forefront of developing innovative medicines for aging-related diseases by integrating genetics with clinical data. The company’s unique approach and strong partnerships position it well in the biopharmaceutical industry.
Keywords: biopharmaceutical, aging diseases, drug development, clinical data, genetics, healthcare, partnerships, research, innovation, targeted medicines.
Company overview
Character Biosciences company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Clifton, United States
- Employees
- 57
- Open positions
- None listed
- Dealroom signal
- 91.8
Valuation & funding
Character Biosciences funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2025 | $17M | $550M | Bausch & Lomb · Section 32 · Catalio Capital Management · aMoon Fund | ↗ |
| SERIES BOther financing | Mar 2025 | $110M | $440M | Bausch & Lomb · KdT Ventures · Luma Group · Innovation Endeavors | ↗ |
| SERIES AOther financing | Sep 2022 | $0 | — | Undisclosed | — |
| EARLY VCOther financing | May 2022 | $18M | $72M | Industry Ventures · Section 32 · Catalio Capital Management · Innovation Endeavors | ↗ |
| SEEDOther financing | Apr 2020 | $3.5M | $14M | Lifeforce Capital | — |
| SEEDOther financing | Sep 2019 | Undisclosed | — |
Growth signals
Character Biosciences website traffic
Latest recorded traffic for Character Biosciences is 2.9K monthly website visits, down 9.4% over the last three months. Character Biosciences's team grew 14% over the past year.
Comparisons
Character Biosciences compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Character Biosciences's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Character Biosciences has talent and traffic
team presence
In the news
Latest news about Character Biosciences
Recent press, funding announcements, and product moves mentioning Character Biosciences — open to read from the original sources.
Market sentiment
What the market is saying about Character Biosciences
An AI-synthesized read of the highest-engagement posts about Character Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Character Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.